Home » Topics » Regulatory » Patents

Patents
RSS

Ulinastatin claimed by Mochida as skin disorder treatment

July 26, 1996

Chugai describes 24-oxo-22-oxavitamin D3 derivatives

July 26, 1996

RPR describes tachykinin NK1 antagonists

July 26, 1996

Pharmacia & Upjohn reveals non-enzymatic protein glycosylation inhibitors

July 19, 1996

Janssen describes agent for decreased intestinal motility

July 19, 1996

CJ-12954: Pfizer's anti-Helicobacter pylori compound

July 19, 1996

Glaxo Wellcome describes alpha1A-adrenoceptor antagonists

July 19, 1996

Terumo discloses fibrinogen (gpIIb/IIIa) antagonists

July 19, 1996

Platelet aggregation inhibitors from Meiji Seika

July 19, 1996

Fibrinogen antagonists from DuPont Merck

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...